Health
Moderna COVID-19 vaccine well-tolerated, generates immune response in older adults: Study – The Indian Express
The study, published in the New England Journal of Medicine, noted that the experimental vaccine, mRNA-1273, was well-tolerated by the older trial participants,…
By: AP | Boston |
Updated: September 30, 2020 7:40:28 pm
According to the researchers from NIAID, older adults are more vulnerable to complications of COVID-19, and are an important population for vaccination. (AP/File)Results from the Phase 1 trial of an investigational COVID-19 vaccine co-developed by researchers at the US National Institute of Allergy and Infectious Diseases (NIAID), and the American biotech company Moderna have shown that it is well-tolerated and generates a strong immune…
-
General23 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
General8 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General20 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News23 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’